DLC1 and cancer: DLC1—a Ras homolog GTPase-activating protein (RhoGAP) that negatively regulates the activity of RhoA-C and is a potent tumour suppressor whose loss has been implicated with numerous cancers [9, 10]—is a notably interesting talin-binding partner.